JP2017511387A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017511387A5 JP2017511387A5 JP2017506619A JP2017506619A JP2017511387A5 JP 2017511387 A5 JP2017511387 A5 JP 2017511387A5 JP 2017506619 A JP2017506619 A JP 2017506619A JP 2017506619 A JP2017506619 A JP 2017506619A JP 2017511387 A5 JP2017511387 A5 JP 2017511387A5
- Authority
- JP
- Japan
- Prior art keywords
- bryostatin
- pharmaceutical composition
- composition according
- once
- weeks
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461981473P | 2014-04-18 | 2014-04-18 | |
| US61/981,473 | 2014-04-18 | ||
| US201461987360P | 2014-05-01 | 2014-05-01 | |
| US61/987,360 | 2014-05-01 | ||
| PCT/US2015/025821 WO2015160851A1 (en) | 2014-04-18 | 2015-04-14 | Methods and compositions for treatment of lipid storage disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017511387A JP2017511387A (ja) | 2017-04-20 |
| JP2017511387A5 true JP2017511387A5 (2) | 2018-04-12 |
Family
ID=54321042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017506619A Pending JP2017511387A (ja) | 2014-04-18 | 2015-04-14 | 脂質蓄積障害の治療のための方法および組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US20170172978A1 (2) |
| EP (1) | EP3131543A4 (2) |
| JP (1) | JP2017511387A (2) |
| KR (1) | KR20170031653A (2) |
| CN (1) | CN107072982A (2) |
| CA (1) | CA2946115A1 (2) |
| IL (1) | IL248494A0 (2) |
| MX (1) | MX2016013680A (2) |
| WO (1) | WO2015160851A1 (2) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11123324B2 (en) | 2016-08-18 | 2021-09-21 | Noster Inc. | Immunomodulator |
| US20210252173A1 (en) * | 2018-04-20 | 2021-08-19 | Retrotope, Inc. | Stabilized polyunsaturated compounds and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU784589B2 (en) | 1999-11-30 | 2006-05-04 | Board Of Trustees Of The Leland Stanford Junior University | Bryostatin analogues, synthetic methods and uses |
| US7256286B2 (en) | 1999-11-30 | 2007-08-14 | The Board Of Trustees Of The Leland Stanford Junior University | Bryostatin analogues, synthetic methods and uses |
| CA2490494A1 (en) | 2002-07-02 | 2004-01-15 | Blanchette Rockefeller Neurosciences Institute | Pkc activation as a means for enhancing sapp.alpha. secretion and improving cognition using bryostatin type compounds |
| US8497385B2 (en) | 2007-08-31 | 2013-07-30 | The Board Of Trustees Of The Leland Stanford Junior University | Bryostatin analogues, synthetic methods and uses |
| WO2009099563A2 (en) | 2008-02-05 | 2009-08-13 | Blanchette Rockefeller Neurosciences Institute | Combination of a nmda receptor channel blocker and a pkc activator for treatment of alzheimer's disease |
| CA2731171C (en) | 2008-07-28 | 2016-10-18 | Blanchette Rockefeller Neurosciences Institute | Pkc-activating compounds for the treatment of neurodegenerative diseases |
| US20120156180A1 (en) | 2009-08-10 | 2012-06-21 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for the treatment of krabbe and other neurodegenerative diseases |
| CA2855932A1 (en) * | 2011-11-13 | 2013-05-16 | Blanchette Rockefeller Neurosciences Institute | Pkc activators and combinations thereof |
| EP3122351A1 (en) | 2014-03-27 | 2017-02-01 | Daniel L. Alkon | Compositions and methods to treat niemann-pick disease |
-
2015
- 2015-04-14 MX MX2016013680A patent/MX2016013680A/es unknown
- 2015-04-14 EP EP15780368.5A patent/EP3131543A4/en not_active Withdrawn
- 2015-04-14 US US15/304,838 patent/US20170172978A1/en not_active Abandoned
- 2015-04-14 US US14/686,711 patent/US9724328B2/en not_active Expired - Fee Related
- 2015-04-14 WO PCT/US2015/025821 patent/WO2015160851A1/en not_active Ceased
- 2015-04-14 KR KR1020167032127A patent/KR20170031653A/ko not_active Withdrawn
- 2015-04-14 CA CA2946115A patent/CA2946115A1/en not_active Abandoned
- 2015-04-14 CN CN201580032762.2A patent/CN107072982A/zh active Pending
- 2015-04-14 JP JP2017506619A patent/JP2017511387A/ja active Pending
-
2016
- 2016-10-25 IL IL248494A patent/IL248494A0/en unknown
-
2019
- 2019-01-15 US US16/247,880 patent/US20190201377A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017518334A5 (2) | ||
| RU2018114447A (ru) | Введение дейтерированных усилителей cftr | |
| JP2014198723A5 (2) | ||
| JP2018534348A5 (2) | ||
| JP2013505205A5 (2) | ||
| JP2012193216A5 (2) | ||
| HRP20150644T1 (hr) | Metoda za lijeäśenje atrijalne fibrilacije | |
| FI3936130T3 (fi) | Valbenatsiinin annostusohjelma hyperkineettisten liikehäiriöiden hoitoon | |
| JP2014526503A5 (2) | ||
| JP2016530291A5 (2) | ||
| JP2015523407A5 (2) | ||
| HK1206246A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
| JP2016511753A5 (2) | ||
| NZ625592A (en) | Compositions and methods for the treatment of hepatic diseases and disorders | |
| EA202090984A1 (ru) | Диспергируемая в полости рта единица дозирования, содержащая эстетрольный компонент | |
| JP2015500223A5 (2) | ||
| JP2015510916A5 (2) | ||
| JP2012502047A5 (2) | ||
| JP2018090566A5 (2) | ||
| JP2017507142A5 (2) | ||
| PH12021553056A1 (en) | Modified release formulations and uses thereof | |
| JP2009517411A5 (2) | ||
| JP2014507475A5 (2) | ||
| BR112023025552A2 (pt) | Composições estabilizadas de apilimod e usos das mesmas | |
| JP2010500284A5 (2) |